Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Azacitidine for treatment of imminent relapse in MDS or AML patients after allogeneic HSCT: results of the RELAZA trial

PaperCitations, authors & open-access status

Azacitidine for treatment of imminent relapse in MDS or AML patients after allogeneic HSCT: results of the RELAZA trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 397 citations, 2011 year and hybrid oa status.

397
Citations
2011
Year
hybrid
OA Status

Related on ScholarIQ

Martin Wermke
Author
Acute Myeloid Leukemia Research
Topic
Acute Myeloid Leukemia Research
Topic
Hematopoietic Stem Cell Transplantation
Topic
Chronic Myeloid Leukemia Treatments
Topic
470M+ articles · free account